Clustering data with hclust algorithm for Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (Study ST000977)
Reversed phase POSOTIVE ION MODE/Endocannabinoids (Analysis AN001599)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 |
|---|---|---|---|---|---|---|---|---|---|
| 1-AG and 2-AG | ME240870 | 0.54 | 1.03 | 0.61 | 2.81 | 0.62 | 0.95 | 0.73 | 1.28 |
| 1-OG and 2-OG | ME240868 | 0.16 | 1.20 | 1.72 | 1.44 | 0.85 | 0.43 | 1.21 | 0.92 |
| PEA | ME240857 | 1.57 | 1.10 | 0.79 | 1.08 | 0.81 | 1.04 | 0.75 | 1.24 |
| SEA | ME240858 | 1.56 | 0.96 | 1.01 | 1.19 | 0.80 | 0.85 | 0.89 | 1.05 |
| AEA | ME240863 | 0.66 | 1.57 | 0.72 | 1.78 | 0.54 | 1.27 | 0.58 | 1.44 |
| DEA | ME240864 | 0.56 | 1.41 | 0.86 | 1.64 | 0.58 | 1.40 | 0.72 | 1.24 |
| Dihomo GLA EA | ME240862 | 0.47 | 1.44 | 0.65 | 1.39 | 0.68 | 1.62 | 0.67 | 0.94 |
| OEA | ME240859 | 0.75 | 1.48 | 0.71 | 1.35 | 0.75 | 1.33 | 0.70 | 1.16 |
| aLEA | ME240861 | 0.57 | 1.13 | 1.04 | 1.30 | 0.79 | 1.41 | 0.65 | 1.35 |
| LEA | ME240860 | 0.55 | 1.30 | 0.79 | 1.30 | 0.75 | 1.43 | 0.71 | 1.34 |
| NO-Gly | ME240866 | 0.81 | 1.24 | 0.88 | 1.07 | 1.15 | 1.02 | 0.94 | 0.79 |
| 1-LG and 2-LG | ME240869 | 0.41 | 1.32 | 0.71 | 1.35 | 0.77 | 1.11 | 1.01 | 1.45 |
| DHEA | ME240865 | 0.69 | 1.18 | 0.90 | 1.19 | 1.08 | 0.98 | 0.83 | 1.40 |
| NA-Gly | ME240867 | 0.43 | 1.25 | 0.92 | 1.46 | 1.02 | 0.99 | 0.95 | 1.05 |
Factors:
| F1 | Ethnicity:Caucasian | Gender:Female | Group:Healthy Control |
| F2 | Ethnicity:Caucasian | Gender:Female | Group:NAFLD |
| F3 | Ethnicity:Caucasian | Gender:Male | Group:Healthy Control |
| F4 | Ethnicity:Caucasian | Gender:Male | Group:NAFLD |
| F5 | Ethnicity:Hispanic | Gender:Female | Group:Healthy Control |
| F6 | Ethnicity:Hispanic | Gender:Female | Group:NAFLD |
| F7 | Ethnicity:Hispanic | Gender:Male | Group:Healthy Control |
| F8 | Ethnicity:Hispanic | Gender:Male | Group:NAFLD |
